# A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis

> clinical trial · VERIFIED · 2026-07-30

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Relapsing Multiple Sclerosis

- Company: Novartis Pharmaceuticals
- Sector: Relapsing Multiple Sclerosis
- Primary source: https://clinicaltrials.gov/study/NCT05344469

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.